Global $6.4 Bn Companion Diagnostics Technologies and Markets, 2019

Global Companion Diagnostics Market

Dublin, May 23, 2023 (GLOBE NEWSWIRE) -- The "Companion Diagnostics: Technologies and Markets" report has been added to ResearchAndMarkets.com's offering.

The global market for companion diagnostics was valued at $5.5 billion in 2021. The market is forecast to grow from $6.4 billion in 2022 at a compound annual growth rate (CAGR) of 15.3% to reach about $13.0 billion by the end of 2027.

The current report provides detailed coverage of the companion diagnostics market. This report highlights the current and future market potential of companion diagnostics, and it includes a detailed analysis of the drivers, opportunities, restraints and challenges in the market.

Precision medicine or personalized medicine is the future of healthcare. PM is currently the most advanced in oncology, but it has broader applications beyond oncology in fields such as neurology and cardiovascular diseases. Companion diagnostics (CDx) has emerged with the advent of personalized medicine.

Companion diagnostics is developed parallel to a new drug via the drug-diagnostic co-development model. The field has expanded from a few oncology drugs with companion diagnostics to involve multiple therapeutic areas, and the number of combinations has increased substantially over the years. The rapidly surging interest of the medical community and pharmaceutical companies in personalized medicine will create demand for companion diagnostics.

This report will provide a detailed analysis of the key factors governing the growth of the companion diagnostics industry, including strategic insights and recommendations for those players looking to expand their markets.

The report also features market projections to 2027 and market ranking for key market players. It also covers the competitive environment and regulatory scenario. The report details the companion diagnostics market share based on product and Service, type of test, technology and application.

Report Includes

Analyses of the global market trends, with historic market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027

Estimation of the actual market size and revenue forecast for the global CDx market in USD million values, and corresponding market share analysis by product and service, technology, application, type of test, and region

Identification of the viable technology drivers and barriers through a holistic review of various platform technologies and their potential applications in the development of new CDx products

Discussion of feasible market opportunities for companion diagnostics products via identification of high-growth applications in different therapeutic areas, with a focus on the biggest and fastest-expanding markets for diseases

Updated information on recent market developments and clinical trials, as well as the leading companies engaged in research and development (R&D) and products in the companion diagnostics reagent pipeline with SWOT analyses

Review of the patents and patent applications on companion diagnostics and deep dive of recent patent publications related to CDx products and technologies

Insight into the recent industry structure of companion diagnostics, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis

Descriptive company profiles of the leading global players, including Abbott Laboratories, Bio-Rad Laboratories Inc., Illumina Inc., Foundation Medicine Inc., Myriad Genetics Inc., F. Hoffmann-La Roche Ltd., Qiagen N.V., and Thermo Fisher Scientific Inc.

Key Attributes:

Report Attribute

Details

No. of Pages

286

Forecast Period

2022 - 2027

Estimated Market Value (USD) in 2022

$6.4 Billion

Forecasted Market Value (USD) by 2027

$13 Billion

Compound Annual Growth Rate

15.3%

Regions Covered

Global

Company Profiles

Abbott

Adaptive Biotechnologies Corp.

Agilent Technologies Inc.

Amoy Diagnostics Co. Ltd.

Almac Group Ltd.

Arup Laboratories

Autogenomics Inc. (Acquired by Prescient Medicine)

Biocartis

Biodesix Inc.

Biofluidica

Biomerieux Sa

Bio-Techne

Cerba Research

Circulogene

Danaher

Diasorin S.P.A.

Exact Sciences Corp.

F. Hoffmann-La Roche Ltd.

Guardant Health Inc.

Hologic Inc.

Icon plc

Illumina Inc.

Invivoscribe Inc.

Maze Therapeutics

Myriad Genetics Inc.

Neogenomics Laboratories

Qiagen

Quest Diagnostics Inc.

Resonance Health Ltd.

Siemens Healthineers AG

Spartan Bioscience Inc.

Sysmex Corp.

Thermo Fisher Scientific Inc.

Trimgen Corp.

Vela Diagnostics Inc.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights2.1 Highlights of the Market for Companion Diagnostics (Cdx)

Chapter 3 Market and Technology Background3.1 Introduction3.2 Personalized Medicine and Biomarkers3.2.1 Predictive Biomarkers3.3 Companion Diagnostics and Complementary Diagnostics3.3.1 Companion Diagnostics Development3.3.2 Cdx Stakeholders3.3.3 Technologies Used in Cdx3.3.4 Applications of Cdx3.3.5 Regulatory Aspects of Cdx

Chapter 4 Global Market for Companion Diagnostics by Product and Service4.1 Market Overview4.2 Market Share and Forecast4.2.1 Instruments4.2.2 Consumables4.2.3 Services

Chapter 5 Global Market for Companion Diagnostics by Type of Test5.1 Market Overview5.2 Market Share and Forecast5.2.1 Ldt-Cdx5.2.2 Commercial Cdx

Chapter 6 Global Market for Companion Diagnostics by Technology6.1 Market Overview6.2 Market Share and Forecast6.2.1 Immunohistochemistry6.2.2 in Situ Hybridization6.2.3 Polymerase Chain Reaction6.2.4 Next-Generation Sequencing6.2.5 Genotyping6.2.6 Others6.2.7 Services

Chapter 7 Global Market for Companion Diagnostics by Application7.1 Market Overview7.2 Market Share and Forecast7.2.1 Cancer7.2.2 Market for the Application of Cdx in Cancer by Type7.2.3 Neurologic Disorders7.2.4 Cardiovascular Disease7.2.5 Infectious Disease7.2.6 Other Diseases

Chapter 8 Global Market for Companion Diagnostics by Region8.1 North America8.1.1 U.S.8.1.2 Canada8.2 Europe8.2.1 Germany8.2.2 U.K.8.2.3 France8.2.4 Italy8.2.5 Rest of Europe8.3 Asia-Pacific8.3.1 China8.3.2 Japan8.3.3 India8.3.4 Rest of Asia-Pacific8.4 Rest of the World

Chapter 9 Industry Structure9.1 Overview9.2 Stakeholders in Companion Diagnostics9.3 Driving Trends in Companion Diagnostics9.4 Business Models of Companion Diagnostics9.5 Grants and Funding in Companion Diagnostics9.6 Collaborations and Partnerships9.7 Mergers and Acquisitions9.7.1 Market Share Analysis9.8 Leading Market Players in Companion Diagnostics Market, by Technology9.8.1 Leading Market Players in Ihc Market9.8.2 Leading Market Players in Ish Market9.8.3 Leading Market Players in Pcr Market9.8.4 Leading Market Players in Ngs Market9.8.5 Leading Market Players in Genotyping Market9.8.6 Leading Market Players in Others (Tropism, Mri) Cdx Market

Chapter 10 Patent Review10.1 Introduction10.2 Patents on Companion Diagnostics Market10.3 Patent Analysis10.3.1 Patents by Year10.3.2 Patents by Top Applicant10.3.3 Patents by Top Owner10.3.4 Patents by Jurisdiction

Chapter 11 Clinical Trials Analysis11.1 Introduction11.2 Clinical Trials and Cdx11.3 Clinical Trials Analysis11.3.1 Clinical Trials Analysis, by Type of Study11.3.2 Clinical Trials Analysis, by Status11.3.3 Clinical Trials Analysis, by Phase11.3.4 Clinical Trials Analysis, by Region11.3.5 Clinical Trials Analysis, by Application11.3.6 Companies With Companion Diagnostics in Clinical Trials

Chapter 12 Analysis of Market Opportunities12.1 Introduction12.2 Market Dynamics12.2.1 Strengths12.2.2 Challenges12.2.3 Opportunities12.2.4 Threats12.3 Impact of the Covid-19 Pandemic

For more information about this report visit https://www.researchandmarkets.com/r/h9tgys

About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

Global Companion Diagnostics Market